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Summary-We studied the prolactin response to TRH in 53 unmedicated psychiatric inpatients. 
The prolactin response of females was significantly greater than the response of male subjects. There 
was no significant difference in the prolactin response to TRH between depressed patients and those 
with other psychiatric diagnoses. There was no significant relationsliii between the prolactin response 
to TRH and the severity of depression, the TSH response to TRH or the resistance to suppression 
of cortisol secretion by dexamethasone. 
INTRODUCTION 
THE THYROTROPIN (TSH) response to the thyrotropin-releasing hormone (TRH) in 
depression has been the subject of numerous studies. It is well established that the TSH 
response to TRH is decreased in some depressed patients (LOOSEN and PRANGE, 1982). 
Studies of the prolactin (PRL) response to TRH in depression are fewer and the results 
are less consistent: the PRL response to TRH in these patients has been reported as 
increased, decreased or normal (LOOSEN and PRANGE, 1982). In this study we examined 
the PRL response to TRH in 53 unmedicated psychiatric inpatients. In addition, we 
investigated the relationship between the PRL and TSH response to TRH and the 
relationship between resistance to suppression of cortisol secretion by dexamethasone and 
the PRL response to TRH. 
SUBJECTS AND METHODS 
We studied 53 psychiatric inpatients (29 women, 24 men). Subjects gave written consent 
to participate in the study and were drug free for at least one week (usually lo-14 days) 
prior to the study. Patients were euthyroid as determined by measurement of T4 RIA, T, 
resin uptake and basal TSH. Patients who had received lithium salts in the three months 
preceding the study were excluded. Diagnoses were made according to the Research 
Diagnostic Criteria (RDC) (SPITZER et al., 1975) on the basis of all clinical information 
and a structured interview (SPITZER and ENDICOTT, 1975) and without access to laboratory 
results. 
After an overnight fast, subjects were awakened between 6:30 and 7:00 a.m. An 
intravenous catheter was inserted between 8:OO and 8:30 a.m. and 500 pg of TRH (Relefact, 
Hoehst-Roussel) were injected intravenously at 9:30 a.m. Subjects remained supine in bed 
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for the duration of the experiment. Blood was drawn 15 min and immediately before, and 
15, 30, 60, 90 and 120 min after the injection. Samples were immediately centrifuged and 
stored at -20°C. PRL was measured by RIA using antibody and standard donated by 
the National Pituitary Agency, Baltimore, Maryland, U.S.A. The interassay and intraassay 
coefficients of variation were 6.5% and 5.5% respectively. the linear range of the assay 
was 0.5-200 ng/ml. TSH was measured by RIA using the Kallestad TSH Kit reagents, 
Austin, Texas, U.S.A. Interassay and intraassay coefficients of variation were 8.8% and 
6.0% respectively at a TSH concentration of 5.9 &ml. 
Within four days following the TRH infusion patients received dexamethasone (1 mg) 
at 11:30 p.m. Cortisol was measured by the transcortin method of Murphy (MURPHY, 
1967). Interassay and intraassay coefficients of variation were 5.6% and 8.9% at a 
cortisol concentration of 10.15 pg/dl. 
Data were analysed by repeated measures analysis of variance using all time points. 
Subjects were grouped by sex and diagnosis. Additional grouping factors were the 
Dexamethasone Suppression Test results (DST) and ATSH. A cortisol level higher than 
5 pg/dl at either 4:00 p.m. or 1 I:00 p.m. was considered abnormal (escape). A ATSH value 
(defined as maximal TSH after TRH minus zero point baseline) equal to or below 7 &ml 
was considered blunted. The relationship between APRL (defined as maximal PRL after 
TRH minus zero point baseline) and age, HRS score and ATSH was examined by the 
Pearson product moment correlation coefficient. The repeated measures analysis of variance 
and Pearson product moment correlation coefficient were performed after logarithmic 
transformation (log 10) of the hormonal values. 
Thirty-two patients, 20 women and 12 men met RDC criteria for Major Depressive 
Disorder (MDD). The remaining 21 patients, 9 women and 12 men, served as Psychiatric 
Controls. Their diagnoses were as follows: Schizophrenia n = 8 (2 women, 6 men), Mania 
n = 7 (5 women, 2 men), Miscellaneous Diagnoses n = 6 (2 women, 4 men). Mean age f 
SD was 39.9 f 14.7 for the MDD group and 32.5 f 14.1 for the Psychiatric Control 
group. Of the 32 patients with MDD, 21 scored at least 15 on the Hamilton Rating Scale 
(HRS), 17-item vesion. HRS score was missing in one patient. Of the 53 patients, 18 (12 
women, 6 men) had abnormal DST results. Twelve of these 18 received a diagnosis of MDD. 
DST results were missing in one patient. Of the 53 patients, 12 (5 women, 7 men) had 
a blunted TSH response to TRH. Of these 12, six received a diagnosis of MDD. 
RESULTS 
There were no differences in baseline PRL levels between men and women (F= 0.2, df 
1,5 1, ns), or between patients with MDD and psychiatric controls (F= 0.1, df 1,5 1, ns). 
The administration of 500 ,ug TRH stimulated PRL release (F=248.5, df 6,294, p < 
0.0001) (Fig. 1). There was a significant main effect for sex (F= 8.1, df 1,49, p < 0.01). 
Neither the main effect for diagnosis (F= 0.0, df 1,49, ns) nor the sex by diagnosis interaction 
(F=0.4, df 1,49, ns) were significant. There were no signifcant differences in the PRL 
response to TRH between patients with normal and abnormal DST results (F= 1.7, df 1.48, 
ns) nor between patients with a normal and a blunted TSH response (F= 0.6, df 1,49, ns). 
There were also no significant differences in the PRL response to TRH of MDD patients 
with a HRS score above or below 15 (F= 3.7, df 1,29, ns), nor between MDD patients 
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FIG 1. Prolactin response to 500 pg of TRH in psychiatric inpatients (n = 53). 
with a HRS score 2 15 and manic and schizophrenic patients (F= 1.5, df 1,34, ns). There 
was a weak positive correlation between APRL and age (r=0.279, df 51, p < 0.05). Neither 
the correlation between APRL and ATSH (r = 0.249, df 5 1, ns), nor the correlation between 
APRL and HRS score in patients with MDD (r= -0.057, df 29, ns) were significant. 
DISCUSSION 
The data presented here indicate that there is no difference in the PRL response to TRH 
between patients with MDD and those with other psychiatric diagnoses. There was also 
no evidence that the severity of depression was associated with the PRL response to TRH. 
The response was significantly greater in women which is consistent with earlier reports 
in normal subjects (JACOBS et al., 1971). The relationship between age and PRL response 
although significant, accounted for only 7.8% of the variance and was not significant when 
data from male and female subjects were analyzed separately. Our data were insufficient 
to examine the relationship between ovarian status and the response of our female subjects. 
Table 1 summarizes the results of previous studies of the PRL response to TRH in 
depression that we are able to locate and which included at least eight depressed subjects. 
Four studies did not include a comparison group as part of the study (EHRENSING et al., 
1974; GREGOIRE et al., 1977; BRAMBILLA et al., 1978; LINNOILA et al., 1979). Instead, the 
results were compared to normative data obtained in the same laboratory in a different 
study or to data obtained at a different research setting. Of the studies which did include 
a comparison group, one reports increased response compared to healthy volunteers (MAEDA 
et a/., 1975), one reports a decreased response in postmenopausal but normal response 
in premenopausal females (LINKOWSKI et al., 1980), one reports a normal response in 75070, 
increased in 7% and blunted response in 18% of the depressed subjects (WINOKUR et al., 
1983) and one reports a decrease response in endogenously depressed women (WITSCHY 
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TABLE 1. PRL RESPONSE TO TRH: SUMMARY OF 14 STUDIES 
Number of Number of 
depressed subjects control subjects Response 
EHRENSING et al. (1974) 8 0 
MAEDA et al. (1975) 13 
GREG~IRE et al. (1977) 19 
BRAMBILLA et a/. (1978) 16 
NAEIJE et al. (1978) 8 
LINNOILA et al. (1979) 8 
16 healthy volunteers 
0 
0 
8 healthy volunteers 
8 barbiturate coma 
0 
LANCER et al. (1980) 28 13 healthy volunteers 
COPPEN et al. (1980) 16 16 healthy volunteers 
LINKOWSKI et al. (1980) 51 38 healthy volunteers 
KIRKBGAARD et a/. (1981) 
TARGUM et al. (1982) 
WINOKUR et al. (1983) 
WITSCHY et al. (1984) 25 20 healthy volunteers 




9 healthy volunteers 
8 psychiatric controls 
13 psychiatric controls 
32 healthy volunteers 










Decreased in post- 
menopausal women 




Normal n = 34 
Blunted n = 8 





eC al., 1984). The remaining five controlled studies report no difference between depressed 
patients and healthy volunteers or psychiatric controls (NAEIJE et al., 1978; LANGER et al., 
1980; COPPEN et al., 1980; KIRKECAARD et al., 198 1; TARGUM et al., 1982). We were also 
unable to demonstrate a difference between our depressed subjects and psychiatric controls. 
This, however, does not exclude the possibility that the response of some of our depressed 
subjects and psychiatric controls would have been found either increased or decreased if 
compared to age- and sex-matched healthy volunteers studied under identical conditions. 
It must also be noted that some evidence for the presence of an impairment in the PRL 
response to TRH in depression is derived from reports of increased responsiveness on repeat 
testing after recovery (GREGOIRE et al., 1977; LANCER et al., 1980; KIRKEGAARD et al., 198 1; 
D’AGATA et al., 1979; ASNIS et al., 1981). Repeat testing, however, was conducted in most 
of these studies while many of the patients were still on tricyclic antidepressants and this 
finding has not been always confirmed (LINKOWSKI et al., 1980). 
The administration of exogenous steroids can affect the PRL response to various stimuli 
including TRH (COPINSCHI et al., 1975; SOWERS et al., 1977; ROSSXER et al., 1980). Thus, 
it is possible that decreased PRL response to TRH when present in certain patients, is 
associated with the presence of disinhibited hypothalamic-pituitary-adrenal cortex function. 
Unlike the results of WITSCHY et al. (1984), we did not find a relationship between the 
presence of abnormal DST results and the PRL response to TRH. The reasons for this 
discrepancy are not readiIy apparent. Finally, in this study we examined the reIationship 
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between the TSH and PRL response to TRH. This question is of some, at least theoretical, 
importance; it has been postulated that the simultaneous presence of a decreased TSH and 
a decreased PRL response to TRH could be the result of increased dopaminergic tone 
(LOOSEN and PRANGE, 1982). Few studies have addressed this question systematically. 
Recently TARCUM et al. (1982) and WITSCHY et al. (1984) reported an association between 
blunted TSH and decreased PRL response to TRH in depressed patients. LOOSEN et al. 
(1983), however, found normal prolactin levels following TRH in depressed patients showing 
TSH blunting. Similarly, we were unable to demonstrate a statistically significant 
relationship between the TSH and PRL response to TRH. Although methodological 
differences (i.e. differences in sex distribution) could be responsible, the exact reasons for 
this discrepancy are not really apparent. Whatever the case it must be emphasized that 
the simultaneous presence of an attenuated TSH and PRL response does not necessarily 
reflect alterations in monoaminergic tone but could be the result of changes in the 
bioavailability of TRH. 
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